Original Article Low-grade fibromyxoid sarcoma: a clinicopathologic and molecular study of 10 genetically confirmed cases
|
|
- Adrian Gray
- 5 years ago
- Views:
Transcription
1 Int J Clin Exp Pathol 2018;11(12): /ISSN: /IJCEP Original Article Low-grade fibromyxoid sarcoma: a clinicopathologic and molecular study of 10 genetically confirmed cases Mengtian Li 1*, Huijiao Chen 1*, Dengchao Shi 2, Min Chen 1, Zhang Zhang 1, Hongying Zhang 1 1 Department of Pathology, West China Hospital, Sichuan University, Chengdu , Sichuan, China; 2 Department of Pathology, Center Hospital of Panzhihua, Panzhihua , Sichuan, China. * Equal contributors. Received September 26, 2018; Accepted November 20, 2018; Epub December 1, 2018; Published December 15, 2018 Abstract: Low-grade fibromyxoid sarcoma (LGFMS) is a rare low-grade malignant fibroblastic tumor, harboring a characteristic FUS-CREB3L2 or FUS-CREB3L1 gene fusion. The authors presented 10 genetically confirmed cases in a Chinese population. To the best of our knowledge, the present series consists of the most genetically confirmed cases from a Chinese medical center in English literature. The clinical, histologic, immunohistochemical, and molecular features of all cases are reviewed. The age of the patients (7 females, 3 males) ranged from 4 to 58 years old (median, 26 y; mean, 27 y). Trunk (4/10, 40%) was the most common site. Microscopically, all the cases exhibited an admixture of myxoid nodules and fibrous zones. The tumor cells were deceptively bland and nuclear pleomorphism was observed in focal areas of one case. Immunohistochemically, neoplastic cells were focally reactive for EMA (1/9, 11.1%), and negative for S-100 protein, CD34, smooth muscle actin, and desmin (0/9). Of the 4 cases stained with MUC4, one showed focal expression and others were interpreted as indeterminate. Surgical excision was performed for all patients. Follow-up information was available for 8 cases, and none developed local recurrence or metastasis at last follow-up (mean 31 months). LGFMS is a distinctive low-grade malignant tumor. The diagnosis of this tumor might be very challenging and it is mistaken for many benign lesions. A combination of clinical studies, careful morphologic analysis, and a full panel of immunomarkers especially genetic studies is helpful in confirming the diagnosis. This tumor type is associated with favorable prognosis. Keywords: Low-grade fibromyxoid sarcoma, FUS rearrangement, fluorescence in situ hybridization Introduction Low-grade fibromyxoid sarcoma (LGFMS) is a distinct entity of malignant fibroblastic soft tissue tumor first described by Evans in 1987 [1-3]. Subsequent studies confirmed Evans discovery and depicted the histologic and immunohistochemical features of this tumor, which exhibited innocuous morphology of a proliferation of bland-looking fibroblastic spindle cells, but, paradoxically, could develop distant metastases [4-8]. FUS-CREB3L2 gene fusion chimera, resulting from t(7;16)(q33;p11), was first discovered by Storlazzi et al. in two cases of LGFMS [9], which has been now widely accepted as a specific genetic change of LGFMS accounting for over 90% of cases, followed by FUS-CREB3L1 and EWSR1-CREB3L1 [10-12]. These characteristic molecular abnormities are extremely useful in the differential and definite diagnosis for LG- FMS. Fluorescence in situ hybridization (FISH) and reverse transcription-polymerase chain reaction (RT-PCR) performed on formalin-fixed, paraffin-embedded (FFPE) tissue sections have been widely accepted as highly sensitive and specific diagnostic tools for determining these characteristic molecular changes in suspicious cases [13, 14]. To our knowledge, there have been 26 series consisting of eight or more cases of LGFMS in English literatures [4-8, 10, 11, 13-31] and 15 of these studies used molecular techniques to confirm the characteristic molecular changes of their cases [10, 11, 13, 14, 20-29, 31]. Therein, only one study came from China, however, without genetic analysis [15]. To better understand the clinicopathologic spectrum of this rare tumor, we describe a
2 Table 1. Clinical information of series of low-grade fibromyxoid sarcoma Case No. Age (y)/ Sex Site Depth (Deep location) Size (cm) Preoperative Duration Treatment Follow-up (mo) Outcome 1 4/F Back Intramuscular 4 3 mo Marginal excision (margin-), radrx 36 NED 2 12/F Thigh Intramuscular 8 Unknown Wide excision (margin-) 43 NED 3 13/M Arm Intramuscular 3 Unknown Marginal excision (margin-) 5 NED 4 22/F Neck Intramuscular mo Marginal excision (margin-) - LTF 5 24/M Thigh Intramuscular 17 1 mo Wide excision (margin-), radrx 10 NED 6 28/M Neck Intramuscular 2 2 y Marginal excision (margin -) - LTF 7 30/F Axilla Intramuscular mo Wide excision (margin-) 4 NED 8 33/F Wrist Subaponeurotic y Marginal excision (margin-) 61 NED 9 44/F Shoulder Intramuscular 7 2 y Wide excision (margin-), radrx 34 NED 10 58/F Breast Breast lump y Excision (margin+) 65 AWD Abbreviation: F, female; M, male; radrx, radiotherapy; NED, no evidence of disease; LTF, lost to follow-up; AWD, alive with disease; +, positive; -, negative. series of 10 cases of LGFMS with characteristic FUS rearrangement confirmed by FISH at one of the largest medical centers in China. Materials and methods Study cases and tumor specimens The present study was approved by the West China Hospital Institutional Review Board. Cases diagnosed as LGFMS with definitive FUS gene rearrangement confirmed by FISH from January 2008 to December 2017 were retrieved from the surgical pathology and consult files of West China Hospital. Finally, 10 cases were included in this study. Histologic evaluation Histologic features of all the 10 cases were reviewed by three pathologists with soft tissue tumor pathology expertise (H.Z., H.C. and Z.Z.) and two general surgical pathologists (M.L. and D.S.). The mitotic count was determined by the greatest number of mitotic figures in 10 consecutive high-power fields (1.73 mm 2 per 10 HPFs) of the most mitotically active areas. Immunohistochemistry Standard immunohistochemical staining was performed on routine 4-μm sections of FFPE tissue, according to the manufacturer s protocols, using the EnVision Plus Detection System (DAKO, Carpinteria, CA) with positive and negative controls. The antibodies used were CD34 (1:100; clonal QBEnd10, Dako), desmin (ready to use; clonal D33, Dako), EMA (1:100; clonal GP1.4, Dako), S-100 protein (1:100; clonal 4C4.9, Dako), smooth muscle actin (1:100; clonal 1A4, Dako), MUC4 (1:300; polyclonal, Biosynthesis Biotechnology) and Ki-67 (1:100; clonal MIB-1, Dako). Fluorescence in situ hybridization (FISH) Vysis LSI dual-color break-apart probes (Vysis Inc, Downers Grove, IL, USA) were used to detect the FUS rearrangement on chromosome 16p11 in interphase FISH. FISH analyses were performed according to an established laboratory protocol, as previously described. FISH assays were carried out on 4-μm-thick FFPE tissue sections [32, 33]. The sections were deparaffined twice in xylene for 30 min, washed in 100% ethanol twice for 5 min, treated with 10 mmol/l citric acid for 10 min in humidified microware and then incubated in 2 sodium saline citrate (2 SSC) for 5 min at 37 C. Tissue sections were digested with 200 μg/ml proteinase K solution (Sigma, St. Louis, MO, USA) at 37 C for 20 min, washed in phosphate-buffered saline (1 PBS) for a brief time, sequentially dehydrated in ethanol (70%, 80%, 100%) and air-dried at room temperature. Tissue sections were denaturized at 85 C for 2 min and hybridized overnight at 37 C in a humidified chamber. The slides were then washed in 0.1% NP40/2 SSC at 76 C for 2 min and again washed with the same solution at room temperature for 2 min. The slides of all cases were scored by two investigators (H.Z. and M.C.) independently. A split signal pattern was considered positive for the FUS gene rearrangement if the distance between the green and the red signals was greater than the total diameter of two signals. A tumor was considered as 5861 Int J Clin Exp Pathol 2018;11(12):
3 Figure 1. A. LGFMS with abrupt transition from fibrous to myxoid zones ( 40); B. LGFMS with classic features of spindle-shaped cells with a bland appearance scattered in alternating fibrous and myxoid areas ( 200). C. Spindle tumor cells of LGFMS arranged in an apparent whorled growth pattern ( 200). D. Typical curvilinear vessels in myxoid areas of LGFMS ( 200). E. Arcades of curvilinear vessels in the myxoid zone of LGFMS ( 200). F. Increased perivascular cellularity in the myxoid zone of LGFMS ( 200). translocation-positive if at least 10% of detected tumor cells exhibited FUS rearrangement. Results Clinical findings The clinical information is summarized in Table 1. The patients (7 females, 3 males) were 4 to 58 years old at the time of diagnosis (median, 26 y; mean, 27 y), and 3 of them (3/10, 30%) were less than 18 years old. The most common clinical manifestation was a slowly growing, painless, deep-situated mass found unconsciously of the corresponding location. The tumor involved the trunk (4/10, 40%), neck (2/10, 20%), upper extremities (2/10, 20%), and thigh (2/10, 20%). All the cases were situated in deep location. Four patients were treated with wide surgical excision and five patients with marginal surgical excision. Only a patient with the breast involved had a positive margin with the residual tumor infiltrating into the pectoral fascia. Three patients were submitted to adjuvant radiotherapy postoperatively. None received chemotherapy. Follow-up information was available for 8 cases, and the interval time varied from 4 to 65 months (median, 34 months; mean, 31 months). All the eight patients were alive without evidence of local recurrence or distant metastasis. Gross and histologic findings The majority of the tumors were well-demarcated, which varied from 0.7 to 17 cm (median, 5.8 cm; mean, 6.6 cm) in maximum dimension. On cut surface, most tumors showed a gray-white, firm appearance with variable glistening foci. Cystic formation (2/10, 20%), focal hemorrhage (2/10, 20%), and necrosis (1/10, 10%) were observed Int J Clin Exp Pathol 2018;11(12):
4 Figure 2. A. A region displayed evident nuclear pleomorphism and atypia (upper left) in contrast to a classic histologic feature (lower right) of LGFMS ( 100). A region with predominant nuclear atypia and evident nuclear pleomorphism. B. ( 200). C. ( 400). Figure 3. LGFMS with focal area of SEF-like morphology. A. ( 100). B. ( 200). Microscopically, all the cases demonstrated areas of classic features of LGFMS, which included contrastingly alternating fibrous and myxoid zones with either an abrupt or a gradual transition, a whorled or patternless growth pattern of uniformly spindle-shaped fibroblastic tumor cells arranged within the fibromyxoid background, prominent arcades of curvilinear capillaries, and perivascular hypercellularity (Figure 1). Tumor cells comprised vaguely, paleeosinophilic cytoplasm and spindle to oval shaped nuclei with slightly nuclear atypia or pleomorphism. Cellularity was low to moderate in most cases. Mitotic figures were generally absent to low (0 to 1 mitotic count per 10 HPFs). None of the tumors showed hyalinizing spindle cell tumors with giant rosettes (HSCTR). Some other features also appeared as following: hyalinizing stroma (4/10, 40%), predominant stori- Immunohistochemical staining and FISH analysis Immunohistochemically, LGFMS were only focally positive for EMA (1/9, 11.1%), and negative for CD34, desmin, smooth muscle actin, and S-100 protein. Immunohistochemical staining for MUC4 was performed in 4 cases. Among them, one showed focal expression, and others were interpreted as indeterminate. Ki-67 index (9/10) varied from 0 to 5% (median, 2%; mean, 1.8%). By FISH, all the 10 cases showed FUS rearrangement (Figure 4). Discussion form growth pattern (1/ 10, 10%), the presence of multinucleated giant cells (1/10, 10%), cyst degeneration (3/10, 30%), hemorrhage (3/10, 30%) and necrosis (2/10, 20%). Also, relatively evident nuclear pleomorphism with increased cellularity (1/10, 10%) (Figure 2) and focal areas resembling sclerosing epithelioid fibrosarcoma (SEF) (1/10, 10%) (Figure 3) were observed. In this study, there was a prominent predilection for females (7/10, 70%). In contrast, major Int J Clin Exp Pathol 2018;11(12):
5 On such occasions, definite diagnosis of LGFMS depends on immunohistochemical analysis and FISH detection for FUS rearrangement after histologic evaluation. Figure 4. FUS gene rearrangement (marked with yellow arrow) was positively detected by FISH analysis. ity of previous large series showed male predominance or no sex preference [5, 16, 26]. Further study is required to determine whether this phenomenon in the current study is just an incidental finding. Our study demonstrated that LGFMS often developed in young adults with the peak incidence around the third and fourth decade, and a proportion of cases occurred in patients aged less than 18 years, which was similar to historical studies [5, 8, 11, 13, 16, 17]. Comparable with previous series, we found LGFMS occurred most commonly in the deep soft tissues of trunk and proximal extremities. Of interest, although breast was reported as a metastatic site of LGFMS [5], it is an extremely rare location for primary LGFMS, as we encountered one case in our study. Grossly, the majority of tumors in the present series were well-demarcated, and some of them showed a variety of cystic, hemorrhage and necrotic changes, similar to previous studies [17, 26]. Microscopically, areas of classic features of LGFMS were observed in all cases of the current study, and some other morphologies including unusual ones, such as increased cellularity with evident nuclear pleomorphism and focal areas resembling SEF were also encountered. Histologic evaluation has been considered as an important step for the definite diagnosis of LGFMS. However, both the deceptively bland histologic features and the wide morphologic spectrum of the tumor have posed diagnostic pitfalls for pathologists. In addition, the increasing use of core biopsy on soft tissue pathology resulting in insufficient tumor specimen has also increased diagnostic challenges. In the current study, neoplastic cells are generally negative for CD34, desmin, S-100 protein, and smooth muscle actin and focally positive for EMA, which was consistent with previous series. MUC4 was regarded as a sensitive and specific marker for LGFMS [31]. However, this marker seems to be not highly sensitive and specific for LGFMS in the present series, which may be resulted from the different antibody clones of the current study and the study of Doyle et al. [31]. In this context, FISH analysis of FUS rearrangement can help to make the definite diagnosis. It is noteworthy that an unusual translocation, EWSR1-CREB3L1, has been recognized in a few cases recently [12, 34]. Therefore, probes detecting this rare rearrangement should be considered when a case highly suspected as LGFMS is FUS translocation-negative. In the present study, a case exhibiting focal areas indistinguishable from sclerosing epithelioid fibrosarcoma (SEF), which had been addressed as hybrid LGFMS/SEF tumor in some studies and gained wide attention [30, 35, 36]. SEF is also an uncommon and more aggressive sarcoma, composed of cords or nests of proliferation of epithelioid cells arranged in heavily sclerotic stroma. Pure SEF and LGFMS have been considered as two different entities mainly owing to their different clinical courses and recurrent molecular changes; that is, the majority of pure SEF cases bear EWRS1-CREB3L1 rather than FUS-CREB3L2. However, the existence of some cases of LF- GMS with SEF-like morphology harboring typically FUS rearrangement as well as some clinicopathologic overlap [30, 31, 37], probably reveal the underlying relationship between these two tumors. Of course, a larger series and multiple molecular methods are required in further study. The differential diagnosis of LGFMS is broad and can be challenging, especially in small biopsy samples. This tumor must be discriminated from other benign, borderline, and malignant fibrous or myxoid lesions, such as desmoid fibromatosis, soft tissue perineurioma, nodular fasciitis, intramuscular myxoma, neu Int J Clin Exp Pathol 2018;11(12):
6 rofibroma, low-grade myxofibrosarcoma, and malignant peripheral nerve sheath tumor (MPNST). Desmoid fibromatosis may be confused with LGFMS especially when extensive myxoid areas exit. Grossly, desmoid fibromatosis is poorlydemarcated and with a more infiltrative growth pattern compared to LGFMS. The characteristic sweeping fascicular growth pattern and the keloid collagen exhibited in desmoid fibromatosis are usually absent in LGFMS. Immunohistochemically, desmoid fibromatosis exhibits nuclear positivity for β-catenin protein (70%), and negativity for MUC4. FUS rearrangement detection is helpful for difficult cases. Soft tissue perineurioma is a benign nerve sheath tumor composed of bland spindleshaped tumor cells which are usually arranged in a storiform whirling or lamellar pattern with a mixture of fibrous and myxoid zones. Perneurioma can mimic LGFMS closely, especially when highly collagenized. But perineurioma usually occurs in superficial locations and histologically lacks prominent vasculature in myxoid areas. In addition, the spindle cells of LGFMS often lack streamer-like cytoplasmic processes, a distinctive histologic feature of perineurioma. Given both tumors can express EMA and claudin-1 variably, molecular tests may be necessary for final diagnosis. Some areas of LGFMS may mimic nodular fasciitis, but the latter lesion typically consists of characterized plump spindle cells posing a tissue culture-like appearance. Other features, such as extravasation of erythrocytes and cleft-like spaces of nodular fasciitis, are nearly absent in LGFMS. Immunohistochemically, the spindle cells within nodular fasciitis often diffusely express SMA and MSA. Importantly, nodular fasciitis has been shown to harbor a characteristic USP6 gene rearrangement. If necessary, detection for rearrangements of USP6 and FUS is useful to discriminate nodular fasciitis from LGFMS. Cellular myxoma, can be easily confused with LGFMS. On this occasion, molecular test for FUS translocation can be extremely helpful to obtain definitive recognition. Neurofibroma often displays a fibromyxoid background resembling LGFMS. But tumor cells in neurofibroma have more slender and wavy nuclei and are consistently positive for S-100 protein. Low-grade myxofibrosarcoma can be easily confused with LGFMS not only for their similar nomenclature, but also for the histologic features. But, myxofibrosarcoma generally occurs in superficial soft tissues of elderly patients with a peak incidence of fifth to seventh decade of life. Histologically, low-grade myxofibrosarcoma exhibits relatively predominant myxoid substances and a more prominent vascular pattern, and more cellular pleomorphism and nuclear atypia. Also, pseudolipoblasts found in myxofibrosarcoma are nearly absent in LGFMS. For difficult cases, detection for FUS translocation can help. MPNST can resemble LGFMS by having alternating hypercellular fascicles and hypocellular myxoid zones, whorled growth pattern of spindle tumor cells and focal areas likened to giant rosettes. Unlike LGFMS, MPNST exhibits more cellularity with more cellular pleomorphism and nuclear atypia. Up to 60% of MPNSTs express S-100 protein. Molecular testing for FUS translocation is useful for distinguishing between the two tumors. Although standard treatment schemes have not been defined at present, surgical excision is the main therapy of LGFMS. Radiotherapy and chemotherapy have showed no significant effect on LGFMS. Therefore, correct preoperative recognition, complete excision with negative margins, and a long-term clinical follow-up are considered as important approaches for LGFMS. In the current study, all eight patients were alive without any local recurrence or metastasis, showing quite favorable prognosis. Some prior studies also showed low recurrence (9%, 13% and 8%, respectively) and metastases (6%, 0 and 0, respectively) [5, 8, 17]. However, LGFMS was a more progressive lesion in some other studies. Guillou et al. and Evans both presented LGFMS as a malignant tumor with a higher rate of local recurrences (20% and 64%, respectively) and distant metastases (27% and 45%, respectively) [16, 26]. The striking discrepancy of follow-up information among these studies, may be interpreted by the reason of preoperative recognition which can decide the 5865 Int J Clin Exp Pathol 2018;11(12):
7 treatment whether complete excision or not, surgical excision with positive or negative margins and the length of follow-up [5, 8, 16, 17, 26]. Herein, we presented the clinicopathological and molecular features of 10 genetically confirmed LGFMS. The tumor cells are very bland and therefore the diagnosis of this tumor might be very challenging. A combination of clinical studies, careful morphologic analysis, and a full panel of immunomarkers, especially genetic studies, is helpful in confirming the diagnosis. This tumor type is associated with favorable prognosis. To the best of our knowledge, the present series contains the most genetically confirmed cases from a Chinese medical center in English literature. Acknowledgements Supported by National Natural Science Foundation of China (no , no ). The study was approved by the West China Hospital Institutional Review Board. Disclosure of conflict of interest None. Address correspondence to: Dr. Hongying Zhang, Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu , Sichuan, China. Tel: ; Fax: ; hy_zhang@scu.edu.cn; hy_zh@263.net References [1] Folpe AL, Hornick JL, Mertens F. Low-grade fibromyxoid sarcoma. WHO classification of tumours of soft tissue and bone. 4th Edition. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, editors. Lyon: Mertens F International Agency for Research on Cancer; pp [2] Borderline and Malignant Fibroblastic/Myofbroblastic Tumors. Enzinger and Weiss s Soft Tissue Tumors. 6th Edition. In: Goldblum JR, Folpe AL, Weiss SW, editors. Philadelphia: Saunders; pp [3] Evans HL. Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol 1987; 88: [4] Evans HL. Low-grade fibromyxoid sarcoma. A report of 12 cases. Am J Surg Pathol 1993; 17: [5] Folpe AL, Lane KL, Paull G and Weiss SW. Lowgrade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of highgrade areas. Am J Surg Pathol 2000; 24: [6] Goodlad JR, Mentzel T and Fletcher CD. Low grade fibromyxoid sarcoma: clinicopathological analysis of eleven new cases in support of a distinct entity. Histopathology 1995; 26: [7] Zamecnik M and Michal M. Low-grade fibromyxoid sarcoma: a report of eight cases with histologic, immunohistochemical, and ultrastructural study. Ann Diagn Pathol 2000; 4: [8] Billings SD, Giblen G and Fanburg-Smith JC. Superficial low-grade fibromyxoid sarcoma (Evans tumor): a clinicopathologic analysis of 19 cases with a unique observation in the pediatric population. Am J Surg Pathol 2005; 29: [9] Storlazzi CT, Mertens F, Nascimento A, Isaksson M, Wejde J, Brosjo O, Mandahl N and Panagopoulos I. Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma. Hum Mol Genet 2003; 12: [10] Panagopoulos I, Storlazzi CT, Fletcher CD, Fletcher JA, Nascimento A, Domanski HA, Wejde J, Brosjo O, Rydholm A, Isaksson M, Mandahl N and Mertens F. The chimeric FUS/CRE- B3l2 gene is specific for low-grade fibromyxoid sarcoma. Genes Chromosomes Cancer 2004; 40: [11] Mertens F, Fletcher CD, Antonescu CR, Coindre JM, Colecchia M, Domanski HA, Downs-Kelly E, Fisher C, Goldblum JR, Guillou L, Reid R, Rosai J, Sciot R, Mandahl N and Panagopoulos I. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Invest 2005; 85: [12] Lau PP, Lui PC, Lau GT, Yau DT, Cheung ET and Chan JK. EWSR1-CREB3L1 gene fusion: a novel alternative molecular aberration of lowgrade fibromyxoid sarcoma. Am J Surg Pathol 2013; 37: [13] Matsuyama A, Hisaoka M, Shimajiri S, Hayashi T, Imamura T, Ishida T, Fukunaga M, Fukuhara T, Minato H, Nakajima T, Yonezawa S, Kuroda M, Yamasaki F, Toyoshima S and Hashimoto H. Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens. Am J Surg Pathol 2006; 30: [14] Matsuyama A, Hisaoka M, Shimajiri S and Hashimoto H. DNA-based polymerase chain 5866 Int J Clin Exp Pathol 2018;11(12):
8 reaction for detecting FUS-CREB3L2 in lowgrade fibromyxoid sarcoma using formalinfixed, paraffin-embedded tissue specimens. Diagn Mol Pathol 2008; 17: [15] Meng GZ, Zhang HY, Bu H and Geng JG. Lowgrade fibromyxoid sarcoma versus fibromatosis: a comparative study of clinicopathological and immunohistochemical features. Diagn Cytopathol 2009; 37: [16] Evans HL. Low-grade fibromyxoid sarcoma: a clinicopathologic study of 33 cases with longterm follow-up. Am J Surg Pathol 2011; 35: [17] Lane KL, Shannon RJ and Weiss SW. Hyalinizing spindle cell tumor with giant rosettes: a distinctive tumor closely resembling low-grade fibromyxoid sarcoma. Am J Surg Pathol 1997; 21: [18] Antonescu CR and Baren A. Spectrum of lowgrade fibrosarcomas: a comparative ultrastructural analysis of low-grade myxofibrosarcoma and fibromyxoid sarcoma. Ultrastruct Pathol 2004; 28: [19] Oda Y, Takahira T, Kawaguchi K, Yamamoto H, Tamiya S, Matsuda S, Tanaka K, Iwamoto Y and Tsuneyoshi M. Low-grade fibromyxoid sarcoma versus low-grade myxofibrosarcoma in the extremities and trunk. A comparison of clinicopathological and immunohistochemical features. Histopathology 2004; 45: [20] Rekhi B, Deshmukh M and Jambhekar NA. Low-grade fibromyxoid sarcoma: a clinicopathologic study of 18 cases, including histopathologic relationship with sclerosing epithelioid fibrosarcoma in a subset of cases. Ann Diagn Pathol 2011; 15: [21] Domanski HA, Mertens F, Panagopoulos I and Akerman M. Low-grade fibromyxoid sarcoma is difficult to diagnose by fine needle aspiration cytology: a cytomorphological study of eight cases. Cytopathology 2009; 20: [22] Ud Din N, Ahmad Z, Zreik R, Horvai A, Folpe AL and Fritchie K. Abdominopelvic and retroperitoneal low-grade fibromyxoid sarcoma: a clinicopathologic study of 13 cases. Am J Clin Pathol 2018; 149: [23] Thway K, Ng W, Benson C, Chapman J and Fisher C. DOG1 expression in low-grade fibromyxoid sarcoma: a study of 11 cases, with molecular characterization. Int J Surg Pathol 2015; 23: [24] Vallejo-Benitez A, Rodriguez-Zarco E, Carrasco SP, Pereira-Gallardo S, Brugal Molina J, Garcia- Escudero A, Robles Frias A, Marcilla D and Gonzalez-Campora R. Expression of dog1 in low-grade fibromyxoid sarcoma: a study of 19 cases and review of the literature. Ann Diagn Pathol 2017; 30: [25] Rose B, Tamvakopoulos GS, Dulay K, Pollock R, Skinner J, Briggs T and Cannon S. The clinical significance of the FUS-CREB3L2 translocation in low-grade fibromyxoid sarcoma. J Orthop Surg Res 2011; 6: 15. [26] Guillou L, Benhattar J, Gengler C, Gallagher G, Ranchere-Vince D, Collin F, Terrier P, Terrier- Lacombe MJ, Leroux A, Marques B, Aubain Somerhausen Nde S, Keslair F, Pedeutour F and Coindre JM. Translocation-positive lowgrade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group. Am J Surg Pathol 2007; 31: [27] Maretty-Nielsen K, Baerentzen S, Keller J, Dyrop HB and Safwat A. Low-grade fibromyxoid sarcoma: incidence, treatment strategy of metastases, and clinical significance of the FUS gene. Sarcoma 2013; 2013: [28] Moller E, Hornick JL, Magnusson L, Veerla S, Domanski HA and Mertens F. FUS-CREB3L2/ L1-positive sarcomas show a specific gene expression profile with upregulation of CD24 and FOXL1. Clin Cancer Res 2011; 17: [29] Thway K, Fisher C, Debiec-Rychter M and Calonje E. Claudin-1 is expressed in perineuriomalike low-grade fibromyxoid sarcoma. Hum Pathol 2009; 40: [30] Prieto-Granada C, Zhang L, Chen HW, Sung YS, Agaram NP, Jungbluth AA and Antonescu CR. A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/ low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases. Genes Chromosomes Cancer 2015; 54: [31] Doyle LA, Moller E, Dal Cin P, Fletcher CD, Mertens F and Hornick JL. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Am J Surg Pathol 2011; 35: [32] Lan T, Chen H, Xiong B, Zhou T, Peng R, Chen M, Ye F, Yao J, He X, Wang Y and Zhang H. Primary pleuropulmonary and mediastinal synovial sarcoma: a clinicopathologic and molecular study of 26 genetically confirmed cases in the largest institution of southwest China. Diagn Pathol 2016; 11: 62. [33] Zhang H, Erickson-Johnson M, Wang X, Oliveira JL, Nascimento AG, Sim FH, Wenger DE, Zamolyi RQ, Pannain VL and Oliveira AM. Molecular testing for lipomatous tumors: critical analysis and test recommendations based on the analysis of 405 extremity-based tumors. Am J Surg Pathol 2010; 34: [34] Rubinstein JC, Visa A, Zhang L, Antonescu CR, Christison-Lagay ER and Morotti R. Primary 5867 Int J Clin Exp Pathol 2018;11(12):
9 low-grade fibromyxoid sarcoma of the kidney in a child with the alternative EWSR1-CREB3L1 gene fusion. Pediatr Dev Pathol 2014; 17: [35] Wang WL, Evans HL, Meis JM, Liegl-Atzwanger B, Bovee JV, Goldblum JR, Billings SD, Rubin BP, Lopez-Terrada D and Lazar AJ. FUS rearrangements are rare in pure sclerosing epithelioid fibrosarcoma. Mod Pathol 2012; 25: [36] Arbajian E, Puls F, Magnusson L, Thway K, Fisher C, Sumathi VP, Tayebwa J, Nord KH, Kindblom LG and Mertens F. Recurrent EWSR1-CRE- B3L1 gene fusions in sclerosing epithelioid fibrosarcoma. Am J Surg Pathol 2014; 38: [37] Doyle LA, Wang WL, Dal Cin P, Lopez-Terrada D, Mertens F, Lazar AJ, Fletcher CD and Hornick JL. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement. Am J Surg Pathol 2012; 36: Int J Clin Exp Pathol 2018;11(12):
A 25 year old female with a palpable mass in the right lower quadrant of her abdomen
May 2016 A 25 year old female with a palpable mass in the right lower quadrant of her abdomen Contributed by: Paul Ndekwe, MD, Resident Physician, Indiana University School of Department of Pathology and
More informationNewer soft tissue entities
Newer soft tissue entities Examples among fibroblastic tumors Turku, May 6, 2010 Markku Miettinen, M.D. AFIP, Washington, DC Fibroblastic neoplasms Solitary fibrous tumor /Hemangiopericytoma Low-grade
More informationSlide Seminar Spanish Society of Pathology
Slide Seminar Spanish Society of Pathology John R. Goldblum, M.D. Chairman, Department of Anatomic Pathology Cleveland Clinic Professor of Pathology Cleveland Clinic Lerner College of Medicine 1921 Original
More informationEvening Specialty Conference Bone and Soft Tissue Pathology. Diagnostic pitfalls in bone and soft tissue pathology
Evening Specialty Conference Bone and Soft Tissue Pathology. Case 1 Elizabeth G Demicco, MD, PhD Mount Sinai Hospital, New York Disclosure of Relevant Financial Relationships USCAP requires that all planners
More informationSelected Pseudomalignant Soft Tissue Tumors of the Skin and Subcutis
Selected Pseudomalignant Soft Tissue Tumors of the Skin and Subcutis Andrew L. Folpe, M.D. Professor of Laboratory Medicine and Pathology Mayo Clinic, Rochester, MN folpe.andrew@mayo.edu 2016 MFMER slide-1
More informationLow-Grade Fibromyxoid Sarcoma of the Head and Neck: A Clinicopathologic Series and Review of the Literature
DOI 10.1007/s12105-015-0647-8 ORIGINAL PAPER Low-Grade Fibromyxoid Sarcoma of the Head and Neck: A Clinicopathologic Series and Review of the Literature Morgan L. Cowan 1 Lester D. Thompson 3 Marino E.
More informationThe Impact of Advances in Molecular Genetic Pathology on the. Classification, Diagnosis and Treatment of Selected Soft Tissue
The Impact of Advances in Molecular Genetic Pathology on the Classification, Diagnosis and Treatment of Selected Soft Tissue Tumors of the Head and Neck Joaquín J. García MD and Andrew L. Folpe MD Department
More information1/10/2018. Soft Tissue Tumors Showing Melanocytic Differentiation. Overview. Desmoplastic/ Spindle Cell Melanoma
2016 MFMER slide-1 2016 MFMER slide-2 2016 MFMER slide-3 Soft Tissue Tumors Showing Melanocytic Differentiation Andrew L. Folpe, M.D. Professor of Laboratory Medicine and Pathology Mayo Clinic, Rochester,
More informationUpdate On Lipomatous Tumors: Old Standbys and New Concepts
Update On Lipomatous Tumors: Old Standbys and New Concepts John R. Goldblum, M.D. Chairman, Department of Anatomic Pathology Cleveland Clinic Professor of Pathology Cleveland Clinic Lerner College of Medicine
More informationDiplomate of the American Board of Pathology in Anatomic and Clinical Pathology
A 33-year-old male with a left lower leg mass. Contributed by Shaoxiong Chen, MD, PhD Assistant Professor Indiana University School of Medicine/ IU Health Partners Department of Pathology and Laboratory
More informationThe Relevance of Cytologic Atypia in Cutaneous Neural Tumors
The Relevance of Cytologic Atypia in Cutaneous Neural Tumors Recent Findings - New Developments New Problems Zsolt B. Argenyi, M.D. Professor of Pathology & Dermatology Director of Dermatopathology Department
More informationSOFT TISSUE TUMOR PATHOLOGY: AN UPDATE
SOFT TISSUE TUMOR PATHOLOGY: AN UPDATE Jason L. Hornick, MD, PhD July 18, 2013 Department of Pathology Brigham and Women s Hospital Harvard Medical School Boston, MA, USA I have no disclosures. New Soft
More informationCASE REPORT Benign epithelioid peripheral nerve sheath tumour resembling schwannoma
Malaysian J Pathol 2014; 36(3) : 217 221 CASE REPORT Benign epithelioid peripheral nerve sheath tumour resembling schwannoma Thejasvi KRISHNAMURTHY MD and SR NIVEDITHA MD, DNB Department of Pathology,
More informationSolitary Fibrous Tumor of the Kidney with Massive Retroperitoneal Recurrence. A Case Presentation
246) Prague Medical Report / Vol. 113 (2012) No. 3, p. 246 250 Solitary Fibrous Tumor of the Kidney with Massive Retroperitoneal Recurrence. A Case Presentation Sfoungaristos S., Papatheodorou M., Kavouras
More informationCase 1 10/2/17. Myxoid Soft Tissue Tumors & Tumor-like Lesions. Myxofibro- or Fibromyxo-?: Myxoid Soft Tissue Tumours We Are All Mixed Up About
Myxoid Soft Tissue Tumors & Tumor-like Lesions Myxofibro- or Fibromyxo-?: Myxoid Soft Tissue Tumours We Are All Mixed Up About Rajiv M. Patel, M.D. RCPA NZ ASM 2017 (4:15-5:00pm, Saturday, 23-09-17) Heterogenous
More informationAtypical Palisaded Myofibroblastoma of Lymph Node: Report of a rare case.
ISPUB.COM The Internet Journal of Pathology Volume 10 Number 1 Atypical Palisaded Myofibroblastoma of Lymph Node: Report of a rare case. V Kinnera, R Nandyala, M Yootla, K Mandyam Citation V Kinnera, R
More information3/27/2017. Disclosure of Relevant Financial Relationships
Ophthalmic Pathology Evening Specialty Conference USCAP 2017 5 th March, 2017 Mukul K. Divatia, MD Assistant Professor Department of Pathology & Genomic Medicine Weill Cornell Medical College Houston Methodist
More information57th Annual HSCP Spring Symposium 4/16/2016
An Unusual Malignant Spindle Cell Lesion to Involve the Breast Erinn Downs-Kelly, D.O. Associate Professor of Pathology University of Utah & ARUP Laboratories No disclosures Case 39 y/o female with no
More informationOriginal Articles. Utilization of Fluorescence In Situ Hybridization in the Diagnosis of 230 Mesenchymal Neoplasms. An Institutional Experience
Original Articles Utilization of Fluorescence In Situ Hybridization in the Diagnosis of 230 Mesenchymal Neoplasms An Institutional Experience Munir R. Tanas, MD; Brian P. Rubin, MD, PhD; Raymond R. Tubbs,
More informationDivision of Pathology
Case 38 Adult woman with a 35mm right breast lump at the 10 o clock position. Excision performed. (Case contributed by Dr Mihir Gudi, KKH) Division of Pathology Merlion, One Fullerton Singapore Diagnosis
More informationCase 2. Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset
Case 2 Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset History 24 year old male presented with a 3 day history of right flank pain, sharp in nature Denies fever, chills, hematuria or
More informationSelf assessment case. Dr Saleem Taibjee Dorset County Hospital, Dorchester
Self assessment case Dr Saleem Taibjee saleemtaibjee@gmail.com Dorset County Hospital, Dorchester Clinical details 34-year-old man: Shave excision Skin tag / papilloma left thigh The best diagnosis is:
More informationFibrosarcoma: a challenging diagnosis
21 Article / Autopsy Case Report Artigo / Relato de Caso de Autópsia Fibrosarcoma: a challenging diagnosis Cristiane Rúbia Ferreira a, Leonardo Gomes da Fonseca b, Gustavo Henrique Munhoz Piotto b, Felipe
More informationSpindle Cell Lesions Of The Breast. Emad Rakha Professor of Breast Pathology and Consultant Pathologist
Spindle Cell Lesions Of The Breast Emad Rakha Professor of Breast Pathology and Consultant Pathologist * SCLs comprise a wide spectrum of diseases, ranging from reactive processes to aggressive malignant
More informationNo financial or other disclosures
Case 2014-5 Esther N. Bit-Ivan, DO Northwestern University Jason Wang, MD Jason Park, MD Korgun Koral, MD Children s Medical Center Charles Timmons, MD Veena Rajaram, MD No financial or other disclosures
More informationPrognostic Significance of Grading and Staging Systems using MIB-1 Score in Adult Patients with Soft Tissue Sarcoma of the Extremities and Trunk
843 Prognostic Significance of Grading and Staging Systems using MIB-1 Score in Adult Patients with Soft Tissue Sarcoma of the Extremities and Trunk Tadashi Hasegawa, M.D. 1 Seiichiro Yamamoto, Ph.D. 2
More informationAvailable online at
90 Available online at www.annclinlabsci.org Paravertebral Low-grade Fibromyxoid Sarcoma with Supernumerary Ring Chromosome: Case Report and Literature Review Yi-Che Chang Chien*, Katalin Károlyi*, and
More informationSoft Tissue Perineurioma
The Korean Journal of Pathology 2009; 43: 266-70 DOI: 10.4132/KoreanJPathol.2009.43.3.266 Soft Tissue Perineurioma - A Case Report - Jun Mo Kim Joon Hyuk Choi Department of Pathology, Yeungnam University
More informationImmunohistochemical Staining for Claudin-1 Can Help Distinguish Meningiomas From Histologic Mimics
Anatomic Pathology / CLAUDIN-1 IN MENINGIOMAS Immunohistochemical Staining for Claudin-1 Can Help Distinguish Meningiomas From Histologic Mimics Hejin P. Hahn, MD, PhD, Elizabeth A. Bundock, MD, PhD, and
More informationDisclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction
Disclosures An update on ancillary techniques in the diagnosis of soft tissue tumors. I have nothing to disclose. Andrew Horvai, MD, PhD Clinical Professor, Pathology Introduction Ancillary techniques
More informationDesmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC
R/O BCC Sabine Kohler, M.D. Professor of Pathology and Dermatology Dermatopathology Service Stanford University School of Medicine Clinical Information 74 y.o. man with lesion on left side of neck r/o
More informationACCME/Disclosures ALK FUSION-POSITIVE MESENCHYMAL TUMORS. Tumor types with ALK rearrangements. Anaplastic Lymphoma Kinase. Jason L.
Companion Meeting of the International Society of Bone and Soft Tissue Pathology The Evolving Concept of Mesenchymal Tumors ALK FUSION-POSITIVE MESENCHYMAL TUMORS Jason L. Hornick, MD, PhD March 13, 2016
More informationCase Report Intraneural malignant perineurioma: a case report and review of literature
Int J Clin Exp Pathol 2014;7(7):4503-4507 www.ijcep.com /ISSN:1936-2625/IJCEP0000923 Case Report Intraneural malignant perineurioma: a case report and review of literature Yong Huang 1, Hongwei Li 1, Zhengwen
More informationEvaluating and Reporting Gastrointestinal Stromal Tumors after Imatinib Mesylate Treatment
The Open Pathology Journal, 2009, 3, 53-57 53 Open Access Evaluating and Reporting Gastrointestinal Stromal Tumors after Imatinib Mesylate Treatment Katie L. Dennis * and Ivan Damjanov Department of Pathology
More informationCase 27 Male 42. Painless, static, well-circumscribed, subcutaneous nodule right lower leg,?lipoma. The best diagnosis is:
Case 27 Male 42. Painless, static, well-circumscribed, subcutaneous nodule right lower leg,?lipoma. The best diagnosis is: A. Angiosarcoma B. Haemangiopericytoma C.Myopericytoma D.Myofibroma E. Angioleiomyoma
More information21/07/2017. Hobnail endothelial cells are not the same as epithelioid endothelial cells
UPDATE IN CUTANEOUS VASCULAR S DERMATOPATHOLOGY SESSION BELFAST PATHOLOGY JUNE 21/2017 Dr E Calonje St John s Institute of Dermatology, London, United Kingdom THE FAMILY OF VASCULAR S WITH EPITHELIOID
More informationThe Genetics of Myoepithelial Tumors: salivary glands, soft tissue and bone
The Genetics of Myoepithelial Tumors: salivary glands, soft tissue and bone Cristina Antonescu, MD Memorial Sloan-Kettering Cancer Center, New York Nothing to declare Disclosure Spectrum of Myoepithelial
More informationSpecial slide seminar
Special slide seminar Tomáš Rozkoš The Fingerland Department of Pathology Charles University Medical Faculty and Faculty Hospital in Hradec Králové Czech Republic Case history, 33 years old resistance
More informationCellular Neurothekeoma
Cellular Neurothekeoma Scott W Binder, MD Pritzker Professor of Pathology & Dermatology Sr. Vice Chair Director, Pathology Clinical Services Chief, Dermatopathology Geffen/UCLA School of Medicine Clinical
More informationAngiomatoid Fibrous Histiocytoma : A Case Report
영남의대학술지제24권제2호 Yeungnam Univ. J. of Med. Vol.24 No.2 p315-321, Dec. 2007 증례 Angiomatoid Fibrous Histiocytoma : A Case Report Joon Hyuk Choi, Woo Jung Sung, Nam Hyuk Lee* Department of Pathology, and *Department
More informationClassification (1) Classification (3) Classification (2) Spindle cell lesions. Spindle cell lesions of bladder (Mills et al.
Non-epithelial tumours and nonepithelial tumour-like lesions of the bladder Dr Jonathan H Shanks The Christie NHS Foundation Trust, Manchester, UK Classification (1) Myofibroblastic proliferations and
More information59 yo male with past medical history of prostate carcinoma, presented with upper abdominal pain
December 2016 59 yo male with past medical history of prostate carcinoma, presented with upper abdominal pain Contributed by: Divya Sharma, MD. Fellow, Gastrointestinal Pathology, Department of Pathology
More informationCase Report Primary cardiac dedifferentiated liposarcoma with homologous and heterologous differentiation: a case report
Int J Clin Exp Pathol 2015;8(8):9662-9666 www.ijcep.com /ISSN:1936-2625/IJCEP0010883 Case Report Primary cardiac dedifferentiated liposarcoma with homologous and heterologous differentiation: a case report
More informationMyxo-inflammatory Fibroblastic sarcoma
AKA Myxo-inflammatory Fibroblastic sarcoma Acral Myxoinflammatory fibroblastic sarcomaam.j.surg.path1998; 22; 911-924 Inflammatory myxoid tumour of soft parts with bizarre giant cells [Pathol.Res.Pract.
More informationCase Report Dendritic fibromyxolipoma in the latissimus dorsi: a case report and review of the literature
Int J Clin Exp Pathol 2015;8(7):8650-8654 www.ijcep.com /ISSN:1936-2625/IJCEP0010580 Case Report Dendritic fibromyxolipoma in the latissimus dorsi: a case report and review of the literature Shuguang Liu
More informationPathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON
Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON Presentation outline Background and epidemiology of sarcomas Sarcoma classification Sarcoma
More informationDisclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction
Disclosures An update on ancillary techniques in the diagnosis of soft tissue tumors. I have nothing to disclose. Andrew Horvai, MD, PhD Clinical Professor, Pathology Introduction Ancillary techniques
More informationKeywords solitary fibrous tumor, dedifferentiation, dedifferentiated solitary fibrous tumor, STAT6, GRIA2, cytokeratin, rhabdomyosarcomatous
758452IJSXXX10.1177/1066896918758452International Journal of Surgical PathologyCreytens et al research-article2018 Pitfalls in Pathology Multifocal Cytokeratin Expression in a Dedifferentiated Solitary
More informationA 42-year-old woman with a liver mass
April 2016 Case of the Month A 42-year-old woman with a liver mass Contributed by: Natalia I. Rush, MD, Resident Physician, Indiana University School of Medicine, Department of Pathology and Laboratory
More informationMalignant Peripheral Nerve Sheath Tumor
C H A P T E R 120 Malignant Peripheral Nerve Sheath Tumor Currently, malignant peripheral nerve sheath tumor (MPNST) is the most commonly used generic name for the neoplasms known in the past as neurosarcoma,
More informationFinancial disclosures
Mesenchymal Neoplasms with Melanocytic Differentiation By Konstantinos Linos MD, FCAP, FASDP Bone, Soft Tissue and Dermatopathology Assistant Professor of Pathology Dartmouth-Hitchcock Medical Center Geisel
More informationKlinisch belang van chromosomale translocatie detectie in sarcomen
Translocations in sarcomas Klinisch belang van chromosomale translocatie detectie in sarcomen Judith V.M.G. Bovée, M.D., Ph.D. Department of Pathology Leiden University Medical Center RNA binding DNA binding
More informationCase Report Soft tissue angiofibroma in a 13-year-old adolescent: case report and literature review
Int J Clin Exp Pathol 2016;9(6):6560-6567 www.ijcep.com /ISSN:1936-2625/IJCEP0025004 Case Report Soft tissue angiofibroma in a 13-year-old adolescent: case report and literature review Yan Qi 1,2*, Xiao-Juan
More informationFun with Fat. General Rules. Case
Fun with Fat General Rules Imaging: location (deep vs. superficial) Superficial lesions are seldom liposarcomas Deep lesions may be benign or malignant Myxoid stroma is common in benign and malignant lesions
More informationDiagnostic problems in uterine smooth muscle tumors
Diagnostic problems in uterine smooth muscle tumors Marina Kos Ljudevit Jurak Clinical Department of Pathology, Clinical Hospital Center Sestre milosrdnice, Zagreb Institute of Pathology, University of
More informationPleomorphic Liposarcoma: A Clinicopathologic Analysis Of 19 Cases
Pleomorphic Liposarcoma: A Clinicopathologic Analysis Of 19 Cases Katharine A. Downes, M.D., John R. Goldblum, M.D., Elizabeth A. Montgomery, M.D., Cyril Fisher, M.D., F.R.C.Path. Departments of Anatomic
More informationUpdate on Cutaneous Mesenchymal Tumors. Thomas Brenn
Update on Cutaneous Mesenchymal Tumors Thomas Brenn Cutaneous Mesenchymal Tumours Wide morphological and biological spectrum Myofibroblastic, smooth muscle, neural, vascular, apidocytic, undifferentiated;
More informationUSCAP 2011: ASDP companion meeting. Steven D. Billings 1
USCAP 2011: ASDP companion meeting. Steven D. Billings (billins@ccf.org) 1 Spindle cell tumors that make you say, Oh $*&%! This lecture will focus on examples of cutaneous tumors that present particular
More informationAn Overview of Genital Stromal Tumors
An Overview of Genital Stromal Tumors By Konstantinos Linos MD, FCAP, FASDP Bone, Soft Tissue and Dermatopathology Assistant Professor of Pathology Dartmouth-Hitchcock Medical Center Geisel School of Medicine
More informationEnterprise Interest Nothing to declare
Enterprise Interest Nothing to declare Diagnoses one would not like to miss in soft tissue pathology early in your career Marta Sbaraglia, MD Department of Pathology Hospital of Treviso University of Padua
More informationأملس عضلي غرن = Leiomyosarcoma. Leiomyosarcoma 1 / 5
Leiomyosarcoma 1 / 5 EPIDEMIOLOGY Exact incidence is unknown, but older studies suggest that leiomyosarcomas comprise approximately 3 percent of soft-tissue sarcomas. Superficial leiomyosarcoma occurs
More informationAANP Diagnostic Slide Session Case 5
AANP Diagnostic Slide Session Case 5 E. Kelly S. Mrachek, M.D. Neuropathology Fellow University of Virginia M. Beatriz S. Lopes, M.D., Ph.D. Neuropathology Program Director University of Virginia Disclosures:
More informationSynovial Sarcoma with Massive Myxoid Feature
The Korean Journal of Pathology 2005; 39: 273-7 Synovial Sarcoma with Massive Myxoid Feature - Case Report - Joon Hyuk Choi Young Ran Shim Young Kyung ae Mi Jin Kim Duk Seop Shin 1 Kil Ho Cho 2 Departments
More informationCase Presentation. Maha Akkawi, MD, Fatima Obeidat, MD, Tariq Aladily, MD. Department of Pathology Jordan University Hospital Amman, Jordan
Case Presentation Maha Akkawi, MD, Fatima Obeidat, MD, Tariq Aladily, MD Department of Pathology Jordan University Hospital Amman, Jordan The 25th Annual Congress of the ADIAP The 8/11/2013 1 5th International
More informationGUT-C 11/30/2017. Debasmita Das, M.D. PGY-1 Danbury Hospital
GUT-C 11/30/2017 Debasmita Das, M.D. PGY-1 Danbury Hospital CLINICAL SUMMARY 8/2017 59 year old female Presented to the ED with 1 month history of general malaise, fever and weight loss PMH: Significant
More informationClear Cell Sarcoma of Right Knee with Bone Marrow Metastasis: A Case Report and review of Literature
Case Report DOI: 10.21276/APALM.2017.1107 Clear Cell Sarcoma of Right Knee with Bone Marrow Metastasis: A Case Report and review of Literature Divya Shelly*, Shashank Mishra, Divya Gupta and Reena Bharadwaj
More informationSayed A. S. Pathology Department, Faculty of Medicine, Al-Azhar University, Cairo
Role of expression of P53, Cyclin D1 and Epidermal growth factor receptor (EGFR) in some benign, intermediate and malignant spindle cell soft tissue tumors Sayed A. S. Pathology Department, Faculty of
More informationS clerosing epithelioid fibrosarcoma is a rare tumour
90 CASE REPORT Primary sclerosing epithelioid fibrosarcoma of the sacrum: a case report and review of the literature L T C Chow, Y H Lui, S M Kumta, P W Allen... Sclerosing epithelioid fibrosarcoma is
More informationFluorescence In Situ Hybridization in the Diagnosis of Soft Tissue Neoplasms: A Review. Munir R. Tanas, MD and John R.
REVIEW ARTICLE Fluorescence In Situ Hybridization in the Diagnosis of Soft Tissue Neoplasms: A Review Munir R. Tanas, MD and John R. Goldblum, MD Abstract: This paper presents an overview of the role of
More informationDiagnostic Value of Immunohistochemistry in Soft Tissue Tumors
Original Article DOI: 10.21276/APALM.1637 Diagnostic Value of Immunohistochemistry in Soft Tissue Tumors Sridevi. V*., Susruthan Muralitharan., and Thanka. J Dept of Pathology, SriMuthukumaran Medical
More informationLAC + USC.
Jeff McDavit,, M.D. LAC + USC mcdavit@usc.edu Clinical History 55 year old male with large, deep, non- tender left thigh mass. Seen at LAC+USC Med Ctr FNA clinic No h/o trauma or radiation Vimentin
More informationTHE FALL AND RISE OF FIBROSARCOMA. Cyril Fisher MD DSc FRCPath. Royal Marsden Hospital/Institute of Cancer Research London UK
THE FALL AND RISE OF FIBROSARCOMA Cyril Fisher MD DSc FRCPath Royal Marsden Hospital/Institute of Cancer Research London UK Bullet points Fibrosarcoma was a common diagnosis until the 1960s. It became
More informationCase Report Cellular Angiofibroma of the Prostate: A Rare Tumor in an Unusual Location
, Article ID 871530, 4 pages http://dx.doi.org/10.1155/2014/871530 Case Report Cellular Angiofibroma of the Prostate: A Rare Tumor in an Unusual Location Inez Wyn, 1 Maria Debiec-Rychter, 2 Ben Van Cleynenbreugel,
More informationPart 1. Slides 1-38, Rita Alaggio Soft tissue tumors Trondheim 14. mars 2013
Part 1 Slides 1-38, Rita Alaggio Soft tissue tumors Trondheim 14. mars 2013 Pediatric Pathology Soft Tissue Tumors AN UPDATE Rita Alaggio Azienda Ospedaliera Università di Padova Soft Tissue Tumors More
More informationSarcomatoid (spindle cell) carcinoma of the cricopharynx presenting as dysphagia
Case Report Sarcomatoid (spindle cell) carcinoma of the cricopharynx presenting as dysphagia Jagtap Sunil V. 1, Shukla Dhirajkumar B. 2, Jagtap Swati S. 3, Havle Abhay D. 4 1 Associate Professor, Department
More informationCase Report A Rare Cutaneous Adnexal Tumor: Malignant Proliferating Trichilemmal Tumor
Case Reports in Medicine Volume 2015, Article ID 742920, 4 pages http://dx.doi.org/10.1155/2015/742920 Case Report A Rare Cutaneous Adnexal Tumor: Malignant Proliferating Trichilemmal Tumor Omer Alici,
More informationHemangioendothelioma with a Prominent Lymphoid Infiltrate Mimicking Follicular Dendritic Cell Tumor: Report of a Case
Journal of Cancer Research Updates, 2013, 2, 135-139 135 Hemangioendothelioma with a Prominent Lymphoid Infiltrate Mimicking Follicular Dendritic Cell Tumor: Report of a Case Justin Kerstetter 1, Mia Perez
More informationSurgical Pathology Evening Specialty Conference USCAP 2015
Surgical Pathology Evening Specialty Conference USCAP 2015 John R. Goldblum, M.D. Chairman, Department of Pathology, Cleveland Clinic Professor of Pathology, Cleveland Clinic Lerner College of Medicine
More informationCase Report A SMARCB1-deficient vulvar neoplasm with prominent myxoid stroma: report of a case showing ERG and FLI1 expression
Int J Clin Exp Pathol 2015;8(6):7526-7532 www.ijcep.com /ISSN:1936-2625/IJCEP0008225 Case Report A SMARCB1-deficient vulvar neoplasm with prominent myxoid stroma: report of a case showing ERG and FLI1
More informationCASE REPORT PLEOMORPHIC LIPOSARCOMA OF PECTORALIS MAJOR MUSCLE IN ELDERLY MAN- CASE REPORT & REVIEW OF LITERATURE.
PLEOMORPHIC LIPOSARCOMA OF PECTORALIS MAJOR MUSCLE IN ELDERLY MAN- CASE REPORT & REVIEW OF LITERATURE. M. Madan 1, K. Nischal 2, Sharan Basavaraj. C. J 3. HOW TO CITE THIS ARTICLE: M. Madan, K. Nischal,
More informationA Clinicopathologic and Immunohistochemical Study of Five Cases
Anatomic Pathology / Sclerosing Rhabdomyosarcoma Sclerosing Rhabdomyosarcoma A Clinicopathologic and Immunohistochemical Study of Five Cases Jian Wang, MD, Xiaoyu Tu, MD, and Weiqi Sheng, MD Key Words:
More informationChondroid lipoma: A rare recently described benign lipomatous tumor
Al-Malki et al. 7 case report peer Reviewed open OPEN ACCESS Chondroid lipoma: A rare recently described benign lipomatous tumor Salman T. Al-Malki, Abdullah S. Al-Khamiss Abstract Introduction: lipomatous
More informationMorphologically Benign Lesions of Soft Tissue and Bone Which Metastasize - What Can We Do?
Andrew L. Folpe, MD Mayo Clinic, Rochester, MN ISBSTP Handout 2010 Morphologically Benign Lesions of Soft Tissue and Bone Which Metastasize - What Can We Do? Introduction Over the past several decades
More informationUncommon pattern in soft tissues epithelioid sarcoma
Romanian Journal of Morphology and Embryology 2005, 46(3):229 233 Uncommon pattern in soft tissues epithelioid sarcoma CARMEN ARDELEANU 1, 2), MARIA COMĂNESCU 3), VIOLETA COMĂNESCU 4), F. ANDREI 1) 1)
More informationCase: The patient is a 24 year- old female who was found to have multiple mural nodules within the antrum. Solid and cystic components were noted on
Case: The patient is a 24 year- old female who was found to have multiple mural nodules within the antrum. Solid and cystic components were noted on imaging. There is no significant past medical history.
More informationA case of giant cell tumour of soft parts in a horse Francesco Cian 1, Sarah Whiteoak 2, Jennifer Stewart 1
A case of giant cell tumour of soft parts in a horse Francesco Cian 1, Sarah Whiteoak 2, Jennifer Stewart 1 1 Animal Health Trust, Newmarket, UK 2 608 Equine and Farm Vets, Rowington, UK Signalment: Horse,
More informationFinancial disclosures
An update on immunohistochemical markers in mesenchymal neoplasms By Konstantinos Linos MD, FCAP, FASDP Assistant Professor of Pathology Geisel School of Medicine at Dartmouth Dartmouth-Hitchcock Medical
More informationInt J Clin Exp Pathol 2016;9(4): /ISSN: /IJCEP
Int J Clin Exp Pathol 2016;9(4):4339-4350 www.ijcep.com /ISSN:1936-2625/IJCEP0022618 Original Article Diagnostic value of TLE1 for synovial sarcoma: immunohistochemical analyses of genetically confirmed
More informationOriginal Article Primary malignant mixed tumor of bone: a case report
Int J Clin Exp Pathol 2015;8(7):8433-8437 www.ijcep.com /ISSN:1936-2625/IJCEP0007490 Original Article Primary malignant mixed tumor of bone: a case report Zhansan Su 1, Zhi Li 1, Baoan Liu 2 1 Department
More informationCase 1. Disclosure. Imaging. Clinical history 5/10/2016. USCAP 2016 Annual Meeting Evening Specialty Conference Bone and Soft tissue Pathology
Disclosure Dr. Agaram has nothing to disclose Case 1 Narsi Agaram, MBBS USCAP 2016 Annual Meeting Evening Specialty Conference Bone and Soft tissue Pathology Clinical history Imaging 1998 A three month
More informationG3.02 The malignant potential of the neoplasm should be recorded. CG3.02a
G3.02 The malignant potential of the neoplasm should be recorded. CG3.02a Conventional adrenocortical neoplasm. Each of the below parameters is scored 0 when absent and 1 when present. 3 or more of these
More information5/10. Pathology Soft tissue tumors. Farah Bhani. Mohammed Alorjani
5/10 Pathology Soft tissue tumors Mohammed Alorjani Farah Bhani Slides are included in this sheet. Objectives: Soft tissue tumors 1. Describe soft tissue tumors. 2. Understand the classification of soft
More informationCharacterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma
Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma Y.-J. Hu 1, X.-Y. Luo 2, Y. Yang 3, C.-Y. Chen 1, Z.-Y. Zhang 4 and X. Guo 1 1 Department
More informationDisclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1
Disclosure Relevant Financial Relationship(s) None Off Label Usage None 2013 MFMER slide-1 Case Presentation A 43 year old male, with partial nephrectomy for a right kidney mass 2013 MFMER slide-2 2013
More informationA case of giant benign localized fibrous tumor of the pleura
Turkish Journal of Cancer Vol.30 / No. 4/2000 A case of giant benign localized fibrous tumor of the pleura ALİ KEMAL UZUNLAR 1, MEHMET YALDIZ 1, İBRAHİM H. ÖZERCAN 2, FAHRİ YILMAZ 1, AKIN E. BALCI 3 1
More informationHistopathological Pattern of Soft Tissue Tumours in 200 Cases.
DOI: 10.21276/aimdr.2016.2.6.PT2 Original Article ISSN (O):2395-2822; ISSN (P):2395-2814 Histopathological Pattern of Soft Tissue Tumours in 200 Cases. Singh Harpal 1, Richika 2, Kundal Ramesh 3 1 Associate
More informationInternational Journal of Allied Medical Sciences
International Journal of Allied Medical Sciences and Clinical Research (IJAMSCR) IJAMSCR Volume 2 Issue 4 Oct-Dec- 2014 Case report Medical research Myxofibrosarcoma of the male breast An infrequent neoplasm:
More informationSurgery for Dedifferentiated Liposarcoma, Presenting Two Radiologically and Pathologically Distinctive Patterns
Surgery for Dedifferentiated Liposarcoma, Presenting Two Radiologically and Pathologically Distinctive Patterns Manabu Hoshi 1, Seiichi Matsumoto 1, Jun Manabe 1, Taisuke Tanizawa 1, Toshio Shigemitsu
More informationContents Part I Introduction 1 General Description 2 Natural History: Importance of Size, Site, Histopathology
Contents Part I Introduction 1 General Description... 3 1.1 Introduction... 3 1.2 Incidence and Prevalence... 5 1.3 Predisposing and Genetic Factors... 8 References... 16 2 Natural History: Importance
More informationGynecologic Evening Specialty Conference. Karuna Garg, MD University of California San Francisco
Gynecologic Evening Specialty Conference Karuna Garg, MD University of California San Francisco Disclosure of Relevant Financial Relationships The USCAP requires that anyone in a position to influence
More information